FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the treatment of cancer. Method uses composition containing paclitaxel and albumin, and an anti-VEGF antibody, where the effective amount of paclitaxel in the nanoparticle-containing composition ranges from about 45 mg/m2 up to about 350 mg/m2 and the effective amount of the anti-VEGF antibody ranges from more than 1 mg/kg to less than 10 mg/kg.
EFFECT: method allows to reduce side effects and increase the effectiveness of treatment.
17 cl, 9 tbl, 32 ex, 19 dwg
Authors
Dates
2018-11-30—Published
2013-11-05—Filed